Appropriations (Section 1)

Amounts in thousands of dollars

FY NCI11 NHLBI NIDCR NIDDK1 NINDS2 NIAID12 NIGMS NICHD3 NEI NIEHS4 NIA NIAMS NIDCD NIMH5
1938 400
1939 400
1940 570
1941 570
1942 565
1943 535
1944 530
1945 561
1946 549
1947 1,821
1948 14,500
1949 14,000
1950 18,900 10,725 1,780 9,234
1951 20,086 14,200 1,955 14,200
1952 19,657 10,083 1,618 9,813
1953 17,887 12,000 1,650 10,474
1954 20,237 15,168 1,740 7,000 4,500 5,738 11,741
1955 21,737 16,668 1,990 8,270 7601 6,180 14,030
1956 24,978 18,898 2,176 10,840 9,861 7,775 18,052
1957 48,432 33,396 6,026 15,885 18,650 13,299 30,006
1958 56,402 35,936 6,430 20,385 21,387 17,400 38,457
1959 75,268 45,613 7,420 31,215 29,403 24,071 49,853
1960 91,257 62,237 10,019 46,862 41,487 34,054 67,470
1961 111,000 86,900 15,500 61,200 56,600 44,000 91,923
1962 142,836 132,912 17,340 81,831 70,812 56,091 3,036 107,711
1963 155,742 147,398 21,199 103,388 83,506 66,142 3,523 139,517
1964 144,340 132,404 19,689 113,679 87,675 68,723 (34,000) 170,990
1965 150,011 124,824 20,083 113,050 87,821 69,847 42,696 186,068
1966 163,768 141,462 23,677 123,203 101,153 77,987 127,188 55,024 226,588
1967 175,656 164,770 28,308 135,687 116,296 90,670 145,113 64,922 24,298
1968 183,356 167,954 30,307 143,954 128,633 94,422 160,284 68,621 17,289
1969 185,150 166,928 29,984 143,888 128,935 96,841 163,514 73,127 17,820
1970 181,454 160,634 28,754 131,761 97,315 97,342 148,294 76,095 22,828 17,423
1971 233,160 194,925 35,440 137,986 103,502 102,368 160,194 94,760 30,032 20,151
1972 378,794 232,627 43,388 153,337 116,732 109,117 173,474 116,427 37,132 26,436
1973 492,205 300,000 46,991 167,316 130,672 113,414 183,171 130,429 38,562 30,956
1974 527,486 289,550 43,959 153,561 121,358 111,089 168,329 125,455 41,177 28,397
1975 691,666 324,630 50,033 173,514 142,498 119,452 187,400 142,435 44,133 35,171
1976 761,727 370,013 51,291 179,516 144,446 126,852 187,312 136,404 50,212 37,660 19,288
1976 TQ 152,901 58,763 7,854 43,719 34,272 27,638 34,078 24,201 4,038 9,519 8,743
1977 815,000 396,661 55,573 219,600 155,500 141,000 205,000 145,543 64,000 51,141 30,000
1978 872,388 447,909 61,728 260,253 178,438 162,341 230,796 166,390 85,400 64,241 37,305
1979 937,129 510,526 65,213 302,767 212,365 191,328 277,628 197,630 105,192 78,080 56,911
1980 999,869 527,488 68,303 341,206 241,966 215,364 312,468 208,953 112,989 83,893 69,988
1981 989,355 549,693 71,114 369,462 252,533 232,077 333,764 220,628 117,983 93,491 75,608
1982 986,617 559,637 71,983 368,191 265,901 235,895 339,862 226,309 127,374 106,270 81,903
1983 987,642 624,259 79,292 413,492 297,064 279,129 369,813 254,324 141,901 164,867 93,996
1984 1,081,581 704,939 88,674 464,026 335,883 319,596 415,937 276,046 155,131 180,597 115,292
1985 1,183,806 805,269 100,688 543,576 396,885 370,965 482,260 313,295 181,678 194,819 144,521
1986 1,203,369 822,292 98,841 544,858 414,727 366,964 492,630 307,958 186,705 188,986 149,762
1987 1,402,837 930,001 117,945 511,124 490,233 545,523 570,916 366,780 216,637 209,294 177,681 138,713
1988 1,469,327 965,536 126,297 534,733 534,692 638,800 632,676 396,811 224,947 215,666 194,746 147,679
1989 1,570,349 1,045,509 130,709 559,494 472,292 740,257 682,213 425,375 231,170 223,403 222,639 159,891 94,166
1990 1,634,332 1,072,354 135,749 581,477 490,409 832,977 681,782 442,914 236,533 229,234 239,455 168,930 117,583
1991 1,714,784 1,126,942 148,918 615,272 541,743 906,251 760,010 478,956 253,241 241,028 323,752 193,247 134,935
1992 1,962,587 1,188,593 158,417 658,925 577,938 959,082 816,844 518,251 268,978 248,575 383,382 203,047 148,789
1993 1,981,351 1,214,793 161,301 681,342 600,078 979,471 832,581 527,788 276,188 251,187 399,924 212,456 154,814 583,651
1994 2,082,267 1,277,880 169,520 716,054 630,650 1,065,593 875,511 555,195 290,260 264,249 420,303 223,280 162,823 613,444
1995 1,913,819 1,257,374 162,430 726,949 627,045 535,199 876778 512,165 291,095 266,566 431,991 228,176 166,660 542,200
1996 2,248,000 1,354,946 182,923 770,582 680,902 1,168,483 946,896 594,547 313,933 288,378 453,541 241,655 176,383 660,549
1997 2,381,149 1,432,529 195,825 815,607 726,407 1,256,659 998,387 631,365 332,597 308,487 485,806 257,003 188,345 701,107
1998 2,547,314 1,531,061 209,415 900,860 780,713 1,351,655 1,065,947 674,766 355,691 330,108 519,279 274,760 200,695 750,241
1999 2,925,247 1,792,509 234,183 1,020,559 902,680 1,569,063 1,197,026 750,485 395,595 375,494 596,126 307,960 229,735 860,638
2000 3,314,554 2,029,424 268,811 1,168,476 1,029,376 1,798,038 1,354,420 858,291 450,300 442,449 686,479 349,968 263,771 973,146
2001 3,754,456 2,298,512 306,211 1,399,684 1,175,854 2,042,124 1,535,378 975,766 510,352 564,810 785,590 396,460 300,418 1,106,305
2002 4,181,233 2,572,667 342,664 1,562,144 1,326,666 2,367,313 1,724,799 1,111,674 580,713 645,422 892,267 448,248 341,675 1,246,640
2003 4,592,348 2,793,733 371,636 1,722,730 1,456,476 3,706,722 1,847,000 1,205,927 633,148 697,767 993,598 486,143 370,382 1,341,014
2004 4,739,255 2,878,691 383,282 1,821,803 1,501,207 4,304,562 1,904,838 1,242,361 653,052 710,701 1,024,754 501,066 382,053 1,381,774
2005 4,825,258 2,941,201 391,829 1,863,584 1,539,448 4,402,841 1,944,067 1,270,321 669,070 724,347 1,051,990 511,157 394,260 1,411,933
2006 4,793,356 2,921,757 389,336 1,854,925 1,534,757 4,414,801 1,935,618 1,264,769 666,756 720,240 1,046,631 507,932 393,458 1,403,515
2007 4,797,639 2,922,929 389,703 1,855,868 1,535,545 4,417,208 1,935,808 1,254,707 667,116 721,119 1,047,260 508,240 393,668 1,404,494
2008 4,830,647 2,938,470 391,778 1,864,945 1,552,113 4,583,344 1,946,104 1,261,381 670,664 723,215 1,052,830 511,291 396,234 1,412,951
2009 4,968,973 3,015,689 402,652 1,911,338 1,593,344 4,702,572 1,997,801 1,294,894 688,480 740,894 1,080,796 524,872 407,259 1,450,491
2010 5,103,388 3,096,916 413,236 1,958,100 1,636,371 4,818,275 2,051,798 1,329,528 707,036 768,993 1,110,229 539,082 418,833 1,489,372
2011 5,058,577 3,069,723 409,608 1,942,224 1,622,003 4,775,968 2,033,782 1,317,854 700,828 762,778 1,100,481 534,349 415,155 1,476,294
2012 5,072,183 3,079,021 410,710 1,947,044 1,626,365 4,490,711 2,430,036 1,321,398 702,712 764,498 1,103,441 535,786 416,273 1,480,265
201313 4,807,450 2,918,317 389,274 1,845,601 1,541,480 4,256,327 2,303,204 1,252,430 666,036 724,597 1,045,849 507,822 394,546 1,403,005
2014 4,923,238 2,988,605 398,650 1,883,474 1,587,982 4,358,841 2,364,147 1,282,595 682,077 742,788 1,171,038 520,053 404,049 1,446,172
201515 4,950,396 2,997,870 399,886 1,899,681 1,605,205 4,358,841 2,371,476 1,286,571 684,191 744,851 1,199,468 521,665 405,302 1,463,036
201616 5,214,701 3,115,538 415,582 1,968,357 1,696,139 4,629,928 2,512,073 1,339,802 715,903 771,051 1,600,191 542,141 423,031 1,548,390
201717,18 5,689,329 3,206,589 425,751 2,010,245 1,783,654 4,906,638 2,650,838 1,380,295 732,618 791,610 2,048,610 557,851 436,875 1,601,931
201817,19 5,964,800 3,383,201 447,735 2,120,797 2,188,149 5,260,210 2,785,400 1,452,006 772,317 828,492 2,574,091 586,661 459,974 1,754,775
201917,20 6,143,892 3,488,335 461,781 2,179,823 2,274,413 5,523,324 2,872,780 1,506,458 796,536 852,056 3,083,410 605,065 474,404 1,870,296
202017,21 6,440,442 3,624,258 477,429 2,264,314 2,444,687 5,885,470 2,937,218 1,556,879 824,090 883,598 3,543,673 624,889 490,692 2,038,374
202117,22,23 6,559,852 3,664,811 484,867 2,281,975 2,513,393 6,069,619 2,991,417 1,590,337 835,714 896,175 3,899,227 634,292 498,076 2,103,708
202217,23,24 6,912,522 3,808,494 501,231 2,345,376 2,611,370 6,322,728 3,092,373 1,683,009 863,918 924,709 4,219,936 655,699 514,885 2,216,976
202317,25 7,320,159 3,982,345 520,163 2,442,171 2,813,925 6,562,279 3,239,679 1,749,078 896,549 997,014 4,407,623 685,465 534,333 2,337,843

1 Beginning in FY 1998, annual levels includes amounts received by the NIDDK consistent with the Special Statutory Funding Program for Type 1 Diabetes Research (special type 1 diabetes), unrelated to their annual appropriations, as initially authorized under Public Law (P.L.) 105-33 (now Section 330B of the Public Health Service Act) and subsequently re-authorized in 2001, 2007, 2008, 2010 and 2012. Between FY 1998-2000, NIDDK received $30.0 million in ‘mandatory’ budget authority each year followed by an increase to an annual level of $100.0 million for FY 2001 through FY 2003. Beginning in FY 2004 continuing through FY 2012, NIDDK has received budget authority of $150.0 million annually for special type 1 diabetes research purposes. For additional information, refer to the program and budget summary maintained by NIDDK at .

2 Starting in 1970, excludes funds for blindness, established as a separate appropriation, the “National Eye Institute.”

3 Congress authorized the transfer of $34,000 from other NIH appropriations to establish the “National Institute of Child Health and Human Development.” Starting in 1976, excludes funds for aging, established as a separate appropriation, the “National Institute on Aging.”

4 In FY 2001, NIH first received a separate appropriation to fund its participation in Superfund Research Program (SRP) activity performed at NIEHS. A significant change occurred in 2000 when Congress chose to provide funding support directly to NIEHS. Previously, the SRP received its funds as pass through dollars from the U.S. Environmental Protection Agency (EPA). From 2000-2005, jurisdiction for SRP funding was assigned to the House Veterans Affairs, Housing and Urban Development and Independent Agencies Appropriation Subcommittee. In 2005, both the House and Senate restructured their Appropriation subcommittees. As a result of this reorganization, budget review jurisdiction for the SRP was assigned to the Appropriation Subcommittee on Interior, Environment, and Related Agencies. A detailed breakdown of budget authority received annually for SRP is found at under the latest appropriations history table, e.g., [2000-2012].

5 NIMH separated from NIH in 1967 and was raised to bureau status in PHS, became a component of PHS's Health Services and Mental Health Administration (HSMHA), later became a component of ADAMHA (successor organization of HSMHA), and rejoined the NIH in 1993.

6 Funding for General Research and Services (GR&S) is shown for FY 1938 to FY 1962, at which time the Division of Research Facilities and Resources (DRFR) was established. In 1969, the Bureau of Health Manpower was renamed the Bureau of Health Professions Education and Manpower Training (BEMT). Within the BEMT, the Division of Research Resources (DRR) was established. Functions of DRFR were transferred to this new Division. In 1970, DRR transferred out of this Bureau. Renamed the National Center for Research Resources in 1990.

7 Starting in 1966, excludes funds for the newly established “National Institute of General Medical Sciences.” Starting in 1970, excludes the “Office of International Operations,” transferred to the “National Institute of Allergy and Infectious Diseases” and the “John E. Fogarty International Center for Advanced Study in the Health Sciences.”

8 Prior to 1970, funds were included under the 2023 ѿý Management Fund. Separate NIH appropriation enacted in 1970.

9 Prior to 1970, Buildings and Facilities funds were included under PHS. Separate NIH appropriation enacted in 1970.

10 “Office of AIDS Research.”

11 Includes amounts specified for facilities repairs and improvements at the National Cancer Institute—Frederick Federally Funded Research and Development Center in Frederick, MD. B&F, often referred to as NCI-Construction. A detailed breakdown of budget authority received for NCI-Construction is found at under the latest appropriations history table, e.g., [2000-2012].

12 Between FY 2002 and FY 2011, the total includes amounts specified for the “Global Fund for HIV/AIDS, malaria, and tuberculosis” (Global Fund) to be transferred to another federal agency. As of FY 2012, NIAID no longer receives appropriations for Global Fund subject to transfer. A detailed breakdown of budget authority received for Global Fund transfer is found at under the latest appropriations history table, e.g., [2000-2012].

13 Amounts reflect post-sequestration levels consistent with the OMB March implementation report defining reductions mandated under the American Taxpayer Relief Act of 2012 (P.L. 112-240), Budget Control Act of 2011 (P.L. 112-25) plus Consolidated and Further Continuing Appropriations Act of 2013 (P.L. 113-6). IC levels and NIH total exclude allocations derived from the Super Storm Sandy supplemental appropriations act, P.L. 113-2, “Disaster Relief Appropriations Act”, 2013.

14 Funds reflect enacted levels as provided under the Consolidated and Continuing Appropriations Act of 2014 (PL 113-76). The name of the National Center for Complementary and Alternative Medicine (NCCAM) has been changed to National Center for Complementary and Integrative Health (NCCIH) in FY 2015 per the Consolidated and Further Continuing Appropriations Act of 2014 (PL 113-235). Future revisions of this table will indicate NCCIH replacing the NCCAM abbreviation.

15 Funds reflect enacted levels as provided under the Consolidated and Further Continuing Appropriations Act of 2015 (P.L. 113-235).

16 Funds reflect enacted levels as provided under the Consolidated Appropriations Act of 2016 (P.L. 114-113).

17 The 21st Century Cures Act, 2016 (P.L. 114-255) authorized an additional $4.8 billion to NIH over a 10 year period, with initial allocations in FY 2017. A total of $352 million Included within the appropriation levels displayed for FY 2017; $300 million for NCI and $52 million for OD. A total of $496 million was included in FY 2018 appropriations; $300 million for NCI, NIMH allocated $43 million, NINDS provided $43 million, and $110 million identified within OD level. For FY 2019, a total of $711 million is authorized; $400 million for NCI, $196 million for OD, and $115 million for NINDS and NIMH. For FY 2020, a total of $492 million was appropriated: $195 million for NCI, $70 million for each of NINDS and NIMH, and $157 million for OD. For FY 2021, a total of $404 million was appropriated: $195 million for NCI, $50 million each for NINDS and NIMH, and $109 million for OD. For FY 2022, a total of $496 million was appropriated: $194 million for NCI, $76 million each for NINDS and NIMH, and $150 million for OD. For FY 2023, a total of $1.085 billion was appropriated: $216 million for NCI, $225 million each for NINDS and NIMH, and $419 million for OD.

18 Discretionary resources of approximately $34.1 billion were received under the Consolidated Appropriations Act, 2017 (Public Law 115-31) as well as $824.443 million derived from PHS Evaluation financing identified in the NIGMS allocation. Mandatory funding for the Special type 1 diabetes account included in the NIDDK allocation was reduced from the FY 2016 level of $150 million to $139.65 million due to sequestration. In addition to other funds appropriated for the OD from P.L. 115-31, $12.6 million is provided to the OD Common Fund from the 10-year Pediatric Research Initiative Fund described in section 9008 of title 26, United States Code.

19 Discretionary resources of nearly $36.24 billion received under the Consolidated Appropriations Act, 2018 (P.L. 115-141) as well as $922.871 million derived from PHS Evaluation financing associated with the NIGMS allocation. Mandatory funding for the Special type 1 diabetes account included in the NIDDK allocation of $150 million was authorized by the Bipartisan Budget Act of 2018 (P.L. 115-123).

20 Discretionary resources of nearly $37.94 billion received under the Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L. 115-245), excluding Superfund Research. An additional $77.3 million in discretionary authority is provided in NIEHS allocation for Superfund Research which is currently under a Continuing Resolution through December 7, 2018 (P.L. 115-245) later extended by another C.R. into February 2019 (P.L. 116-5). NIGMS allocation includes $1,147 million derived from PHS Evaluation financing. Mandatory funding for the Special type 1 diabetes account is included in the NIDDK allocation of $150 million as authorized by the Bipartisan Budget Act of 2018 (P.L. 115-123).

21 NIH Program Level of $41.64 billion is comprised primarily of $40.31 billion discretionary appropriations received under Further Consolidated Appropriations Act, 2020 (P.L. 116-94). The discretionary sum include $81 million provided in NIEHS allocation for Superfund Research. Additional resources involve PHS Evaluation for NIGMS and Mandatory account funding for NIDDK. NIGMS level includes $1.231 billion derived from PHS Evaluation financing. Special type 1 diabetes mandatory dollars for NIDDK totaled $150 million.

22 Amounts exclude supplemental appropriations enacted in FY 2020 for COVID-19 research from P.L. 116-123, P.L. 116-136, P.L. 116-139, and P.L. 116-260. IC distribution of the additional budgetary resources for COVID-19 supplemental appropriations is furnished in the OB website's Appropriation History for FY 2020-2022 Supplementary Data Table.

23 Discretionary resources of slightly over $41.5 billion received under the Consolidated Appropriations Act, 2021 (P.L. 116-260). NIGMS allocation includes $1.272 billion derived from PHS Evaluation financing and NIDDK includes mandatory funding for the Special type 1 diabetes account of $150 million.

24 Discretionary resources of slightly over $43.7 billion received under the Consolidated Appropriations Act, 2022 (P.L. 117-103). NIGMS allocation includes $1.309 billion derived from PHS Evaluation financing and NIDDK includes mandatory funding of $141.450 million for the Special type 1 diabetes account. Note that P.L. 117-103 authorized the establishment of Advanced Research Projects Agency for Health (ARPA-H) within the Department Health and Human Services with authority to transfer to NIH.

25 Discretionary resources of slightly over $46.1 billion received under the Consolidated Appropriations Act, 2023 (P.L. 117-328). NIGMS allocation includes $1.412 billion derived from PHS Evaluation financing and NIDDK includes $141.5 million mandatory funding for the Special type 1 diabetes account.

This page last reviewed on November 14, 2023